Published • loading... • Updated
Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell ...
Summary by Enid News & Eagle
1 Articles
1 Articles
Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell ...
FULLERTON, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) ("Liminatus" or the "Company"), a biotechnology company developing innovative cancer therapies, today announced that it has amended and restated the previously announced definitive merger agreement with InnocsAI…
Coverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
